Scientists at Florida International University have developed a promising new compound that could slow the progression of ...

Research from FIU scientists have discovered a promising new compound that could slow the progression of Parkinson's disease ...

For decades, treatment of Parkinson’s disease has centered on replacing dopamine, the neurotransmitter whose decline drives ...

Aspen's sasineprocel is an autologous induced pluripotent stem cell (iPSC) derived dopaminergic neuron precursor cell (DANPC) ...

Sasineprocel’s encouraging Phase I/IIa data positions autologous iPSC-derived dopaminergic neuron therapy as a potential monotherapy challenger in Parkinson’s disease (PD), signaling a shift toward ...

The firm intends to launch the trial based on positive results from an open-label Phase I/IIa trial of sasineprocel, previously known as ANPD001.

Northwestern Medicine scientists have discovered that an FDA-approved compound promotes neuroprotective effects in ...

The approach harnesses the power of bacteria to transform post-consumer plastic into L-DOPA, a frontline medication for the ...

Two induced pluripotent stem cell therapies receive conditional approval in Japan after small clinical trials showed symptom improvement in Parkinson’s and heart failure.

Scientists have discovered a way of making a drug for Parkinson’s disease from used plastic bottles, saying it shows how waste materials can be “reimagined as valuable resources”. Developed by a team ...

GOTHENBURG, SE / ACCESS Newswire / March 17, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and ...